Edmond de Rothschild Holding’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.6M | Buy |
83,510
+11,793
| +16% | +$1.55M | 0.14% | 128 |
|
|
2026
Q1 | $10M | Buy |
71,717
+2,199
| +3% | +$308K | 0.14% | 134 |
|
|
2025
Q4 | $8.53M | Buy |
69,518
+61,937
| +817% | +$7.53M | 0.12% | 140 |
|
|
2025
Q3 | $841K | Buy |
7,581
+700
| +10% | +$79.6K | 0.01% | 304 |
|
|
2025
Q2 | $763K | Sell |
6,881
-1,012
| -13% | -$108K | 0.01% | 305 |
|
|
2025
Q1 | $884K | Buy |
7,893
+578
| +8% | +$59.6K | 0.02% | 286 |
|
|
2024
Q4 | $676K | Hold |
7,315
| – | – | 0.01% | 305 |
|
|
2024
Q3 | $613K | Sell |
7,315
-145
| -2% | -$11.1K | 0.01% | 317 |
|
|
2024
Q2 | $512K | Sell |
7,460
-214,222
| -97% | -$14.3M | 0.01% | 340 |
|
|
2024
Q1 | $16.2M | Sell |
221,682
-1,861
| -0.8% | -$143K | 0.27% | 97 |
|
|
2023
Q4 | $18.1M | Sell |
223,543
-448
| -0.2% | -$34.9K | 0.32% | 82 |
|
|
2023
Q3 | $16.8M | Buy |
223,991
+23,322
| +12% | +$1.79M | 0.34% | 81 |
|
|
2023
Q2 | $15.5M | Hold |
200,669
| – | – | 0.31% | 86 |
|
|
2023
Q1 | $16.6M | Sell |
200,669
-202,244
| -50% | -$16.8M | 0.38% | 74 |
|
|
2022
Q4 | $34.6M | Sell |
402,913
-50,970
| -11% | -$4.04M | 0.8% | 36 |
|
|
2022
Q3 | $28M | Sell |
453,883
-17,779
| -4% | -$1.12M | 0.74% | 34 |
|
|
2022
Q2 | $29.2M | Sell |
471,662
-46,679
| -9% | -$2.89M | 0.71% | 41 |
|
|
2022
Q1 | $30.8M | Sell |
518,341
-19,683
| -4% | -$1.26M | 0.67% | 46 |
|
|
2021
Q4 | $39.1M | Sell |
538,024
-136,753
| -20% | -$9.42M | 0.84% | 31 |
|
|
2021
Q3 | $47.1M | Sell |
674,777
-40,988
| -6% | -$2.88M | 1.09% | 19 |
|
|
2021
Q2 | $49.3M | Buy |
715,765
+80,215
| +13% | +$5.36M | 1.14% | 16 |
|
|
2021
Q1 | $41.1M | Buy |
635,550
+26,942
| +4% | +$1.74M | 1.13% | 16 |
|
|
2020
Q4 | $35.5M | Sell |
608,608
-11,235
| -2% | -$678K | 1.19% | 12 |
|
|
2020
Q3 | $39.2M | Buy |
619,843
+4,822
| +0.8% | +$334K | 1.55% | 9 |
|
|
2020
Q2 | $47.3M | Sell |
615,021
-2,680
| -0.4% | -$205K | 1.95% | 7 |
|
|
2020
Q1 | $46.2M | Sell |
617,701
-256,658
| -29% | -$17.7M | 2.42% | 4 |
|
|
2019
Q4 | $56.8M | Sell |
874,359
-88,389
| -9% | -$5.76M | 2.24% | 6 |
|
|
2019
Q3 | $61M | Sell |
962,748
-77,172
| -7% | -$5.04M | 2.44% | 5 |
|
|
2019
Q2 | $70.3M | Sell |
1,039,920
-52,847
| -5% | -$3.48M | 2.64% | 2 |
|
|
2019
Q1 | $71M | Buy |
1,092,767
+30,153
| +3% | +$2M | 2.46% | 4 |
|
|
2018
Q4 | $66.5M | Buy |
1,062,614
+56,382
| +6% | +$3.94M | 2.33% | 5 |
|
|
2018
Q3 | $77.7M | Sell |
1,006,232
-110,133
| -10% | -$8.32M | 2.21% | 6 |
|
|
2018
Q2 | $79.1M | Buy |
1,116,365
+3,911
| +0.4% | +$276K | 2.26% | 4 |
|
|
2018
Q1 | $83.9M | Sell |
1,112,454
-137,739
| -11% | -$10.9M | 2.44% | 3 |
|
|
2017
Q4 | $89.6M | Sell |
1,250,193
-121,659
| -9% | -$9.24M | 2.57% | 3 |
|
|
2017
Q3 | $111M | Sell |
1,371,852
-53,384
| -4% | -$4.08M | 3.16% | 1 |
|
|
2017
Q2 | $101M | Sell |
1,425,236
-60,268
| -4% | -$4.01M | 2.84% | 3 |
|
|
2017
Q1 | $101M | Buy |
1,485,504
+280,714
| +23% | +$19.7M | 2.67% | 5 |
|
|
2016
Q4 | $86.3M | Buy |
1,204,790
+240,992
| +25% | +$17.9M | 2.39% | 5 |
|
|
2016
Q3 | $76.3M | Buy |
963,798
+469,501
| +95% | +$38.1M | 2.31% | 5 |
|
|
2016
Q2 | $41.2M | Sell |
494,297
-27,141
| -5% | -$2.41M | 1.32% | 18 |
|
|
2016
Q1 | $47.9M | Buy |
521,438
+34,813
| +7% | +$3.14M | 1.53% | 10 |
|
|
2015
Q4 | $49.2M | Buy |
486,625
+9,073
| +2% | +$944K | 1.31% | 15 |
|
|
2015
Q3 | $46.9M | Buy |
477,552
+9,814
| +2% | +$1.09M | 1.16% | 23 |
|
|
2015
Q2 | $54.8M | Buy |
+467,738
| New | +$51.1M | 1.18% | 23 |
|
Other funds holding GILD
Edmond de Rothschild Holding's GILD Position: Q2 2026 in Review
Edmond de Rothschild Holding increased its Gilead Sciences (GILD) stake by 16% in Q2 2026, buying an estimated $1.55M and bringing the position to 83,510 shares worth $10.6M. The position accounts for 0.14% of the portfolio, ranked #128.
Edmond de Rothschild Holding first reported a position in GILD in Q2 2015 and has held it in 45 quarters since. The position peaked at $111M in Q3 2017. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Edmond de Rothschild Holding held 83,510 shares of Gilead Sciences worth $10.6M as of Q2 2026.
- Edmond de Rothschild Holding bought 11,793 Gilead Sciences shares in Q2 2026, an estimated $1.55M.
- Gilead Sciences made up 0.14% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #128 holding.
- Edmond de Rothschild Holding first reported a position in Gilead Sciences in Q2 2015 and has held it in 45 quarters since.
- Edmond de Rothschild Holding's Gilead Sciences position peaked at $111M in Q3 2017.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.